Overlap between molecular markers expressed by naturally occurring CD4 +CD25 + regulatory T cells and antigen specific CD4 +CD25 + and CD8 +CD28 − T suppressor cells
Alloantigen specific CD8 +CD28 − T suppressor (T S) cells differ from naturally occurring CD4 +CD25 + T-regulatory (natural T R) cells not only by their phenotype but also by their mechanism of action. Natural T R have been extensively studied, leading to the identification of characteristic “molecu...
Saved in:
Published in | Human immunology Vol. 65; no. 11; pp. 1297 - 1306 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.11.2004
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Alloantigen specific CD8
+CD28
− T suppressor (T
S) cells differ from naturally occurring CD4
+CD25
+ T-regulatory (natural T
R) cells not only by their phenotype but also by their mechanism of action. Natural T
R have been extensively studied, leading to the identification of characteristic “molecular markers” such as Forkhead box P3 (FOXP3), glucocorticoid-induced tumor necrosis factor receptor-related protein (GITR) and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). We have investigated the expression of these genes in alloantigen specific T
S and CD4
+CD25
+ T regulatory (T
R) cells and found that they are expressed at levels similar to those observed in natural T
R. Furthermore, similar to natural CD4
+CD25
+ T
R, antigen-specific CD8
+CD28
−CD62L
+ T
S cells have more suppressive capacity than CD8
+CD28
−CD62L
− T
S cells. In spite of these similarities, natural T
R are not antigen-specific and inhibit other T cells by T cell-to-T cell interaction, whereas T
S are antigen-specific and exert their inhibitory function by interacting with antigen-presenting cells and render them tolerogenic to other T cells. The molecular characterization of T
S cells may contribute to a better understanding of mechanisms involved in inhibition of immune responses in autoimmunity, transplantation, and chronic viral infection. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0198-8859 1879-1166 |
DOI: | 10.1016/j.humimm.2004.09.004 |